OMERS, Allianz et AXA IM - Real Assets annoncent l’investissement dans la Fibre jusqu'au domicile (« Fibre to the Home Business – Ftth ») d’Altice France
December 02, 2018 20:27 ET
|
Ontario Municipal Employees Retirement System
TORONTO, MUNICH (Allemagne), et PARIS, 03 déc. 2018 (GLOBE NEWSWIRE) -- Un Consortium dirigé majoritairement par OMERS Infrastructure, y compris Allianz Capital Partners (ACP) et AXA IM - Real...
Editas Medicine Announces Pre-Clinical Data Supporting Novel Approach for Treatment of Sickle Cell Disease and Beta-Thalassemia
December 02, 2018 19:35 ET
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., Dec. 02, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced results from experiments to demonstrate expanded CRISPR...
Spark Therapeutics Announces Updated Data on SPK-8011 from Ongoing Phase 1/2 Dose-escalation Clinical Trial in Hemophilia A at 60th American Society of Hematology (ASH) Annual Meeting and Exposition
December 02, 2018 19:30 ET
|
Spark Therapeutics, Inc.
Preliminary Phase 1/2 data for investigational SPK-8011 for hemophilia A show dramatic reductions in bleeds and infusions for first 12 participants with an encouraging safety profile, as of Nov. 2,...
GBT to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Provide a Regulatory Update for Voxelotor
December 02, 2018 19:00 ET
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Dec. 02, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that the company will host a conference call to...
Nautilus Provides Corporate Update
December 02, 2018 18:25 ET
|
Nautilus Minerals Inc.
VANCOUVER, British Columbia, Dec. 02, 2018 (GLOBE NEWSWIRE) -- Nautilus Minerals Inc. (TSX:NUS, OTC:NUSMF Nasdaq Intl Designation) (the "Company" or "Nautilus") provides the following corporate...
miRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 02, 2018 17:00 ET
|
Miragen Therapeutics, Inc.
BOULDER, Colo., Dec. 02, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted...
Santa Fe Group announces the sale of their Australian business in a management buy out - Company announcement No 10/2018
December 02, 2018 16:53 ET
|
Santa Fe Group
Copenhagen, 2 December 2018 Santa Fe Group A/S has reached an agreement, in the form of a Term Sheet, with Kobus Fourie, Managing Director for Santa Fe Australia, whereby the Santa Fe and...
Larson Electronics Releases 2018 Ford F150 No-Drill 24”x12” Magnetic Mounting Plate for Magnetic Spotlights
December 02, 2018 16:15 ET
|
Larson Electronics, LLC
KEMP, Texas, Dec. 02, 2018 (GLOBE NEWSWIRE) -- Larson Electronics, a Texas-based company with over 40 years of experience spearheading the industrial lighting sector, announced the release of a...
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Inuvo, ConvergeOne, and Owens Realty on Behalf of Stockholders and Encourages Investors to Contact the Firm
December 02, 2018 15:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 02, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Inuvo, Inc., ConvergeOne...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acadia, TG Therapeutics, Namaste, and Huazhu Group and Encourages Investors to Contact the Firm
December 02, 2018 15:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 02, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Acadia Healthcare Company,...
- June 15, 2024 08:57 ET MULTIMEDIA UPDATE -- Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS
- June 14, 2024 21:21 ET Pik'r Range Picking Robot Enhances U.S. Open Experience at Pinehurst